PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS
The aim of the study is to individualize prevention of thrombosis in abdominal surgery, using assessment of hemostasis functional state. The key sign of hemostasis functional state is the character of the blood clot depends on thromboelastography or electrocoagulography. Medi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2017-01-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/117 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849696756075331584 |
|---|---|
| author | S. A. Shaposhnikov S. V. Sinkov I. B. Zabolotskikh |
| author_facet | S. A. Shaposhnikov S. V. Sinkov I. B. Zabolotskikh |
| author_sort | S. A. Shaposhnikov |
| collection | DOAJ |
| description | The aim of the study is to individualize prevention of thrombosis in abdominal surgery, using assessment of hemostasis functional state. The key sign of hemostasis functional state is the character of the blood clot depends on thromboelastography or electrocoagulography. Medication for prevention of thrombosis may be started over 6 to 8 hours after the end of surgery in hemorrhagic variant of hemostasis subcompensation. In this case anticoagulant of choice is unfractionated heparin given in continuous infusion 100-500 units/hour (1-5 units/kg/hour). As blood clot is stabilized, anticoagulation changeover to low molecular weight heparin, the drug of choice is the dalteparin. In those patients who receive prolonged antithrombotic therapy, length of preoperative bridge therapy may vary, according the structural features of formed clot (based on the electrocoagulography data obtained directly prior to routine anticoagulant injection). In the presence of dense clot (i.e., in thrombotic variant of haemostasis subcompensation) last injection of low molecular weight heparin may be done in 12 hours before surgery without risk of bleeding. |
| format | Article |
| id | doaj-art-ca99cd33f8b245c8a8a42e9e13f0141d |
| institution | DOAJ |
| issn | 2076-3093 2307-0501 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Bashkir State Medical University |
| record_format | Article |
| series | Креативная хирургия и онкология |
| spelling | doaj-art-ca99cd33f8b245c8a8a42e9e13f0141d2025-08-20T03:19:21ZengBashkir State Medical UniversityКреативная хирургия и онкология2076-30932307-05012017-01-0102818610.24060/2076-3093-2012-0-2-81-86117PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERSS. A. Shaposhnikov0S. V. Sinkov1I. B. Zabolotskikh2Kuban State Medical UniversityKuban State Medical UniversityKuban State Medical UniversityThe aim of the study is to individualize prevention of thrombosis in abdominal surgery, using assessment of hemostasis functional state. The key sign of hemostasis functional state is the character of the blood clot depends on thromboelastography or electrocoagulography. Medication for prevention of thrombosis may be started over 6 to 8 hours after the end of surgery in hemorrhagic variant of hemostasis subcompensation. In this case anticoagulant of choice is unfractionated heparin given in continuous infusion 100-500 units/hour (1-5 units/kg/hour). As blood clot is stabilized, anticoagulation changeover to low molecular weight heparin, the drug of choice is the dalteparin. In those patients who receive prolonged antithrombotic therapy, length of preoperative bridge therapy may vary, according the structural features of formed clot (based on the electrocoagulography data obtained directly prior to routine anticoagulant injection). In the presence of dense clot (i.e., in thrombotic variant of haemostasis subcompensation) last injection of low molecular weight heparin may be done in 12 hours before surgery without risk of bleeding.https://www.surgonco.ru/jour/article/view/117thrombosis preventionabdominal surgerybleeding |
| spellingShingle | S. A. Shaposhnikov S. V. Sinkov I. B. Zabolotskikh PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS Креативная хирургия и онкология thrombosis prevention abdominal surgery bleeding |
| title | PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS |
| title_full | PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS |
| title_fullStr | PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS |
| title_full_unstemmed | PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS |
| title_short | PERIOPERATIVE PREVENTION OF THROMBOSIS IN PATIENTS WITH HEMOSTASIS DISORDERS |
| title_sort | perioperative prevention of thrombosis in patients with hemostasis disorders |
| topic | thrombosis prevention abdominal surgery bleeding |
| url | https://www.surgonco.ru/jour/article/view/117 |
| work_keys_str_mv | AT sashaposhnikov perioperativepreventionofthrombosisinpatientswithhemostasisdisorders AT svsinkov perioperativepreventionofthrombosisinpatientswithhemostasisdisorders AT ibzabolotskikh perioperativepreventionofthrombosisinpatientswithhemostasisdisorders |